Private equity firm Thoma Bravo has committed capital to French occupational health software provider padoa through its €1.8bn Europe Fund, which closed in 2025. Existing investors Five Arrows and Kamet Ventures are also participating alongside the company’s founders. The deal fits Thoma Bravo’s push into niche enterprise software.

padoa serves occupational health centers, employers and employees in France and across the continent, positioning it as a niche yet scalable SaaS play. By bolstering AI capabilities, Thoma Bravo aims to automate case management and risk analytics, which could sharpen the firm’s value proposition against larger health‑tech rivals. This should cut admin costs for clients.

The funding round, though undisclosed in size, signals confidence in digital health workflows as European employers tighten compliance requirements. With backing from seasoned investors, padoa is poised to accelerate product rollout and capture market share in Germany, Austria and Switzerland. Analysts note the DACH market tops €2 billion in occupational health spend, offering a runway. The deal cements Thoma Bravo’s push into the European health‑software sector.